Results 211 to 220 of about 24,030 (281)

American Epilepsy Society Clinical Practice Guideline: Infantile Epilepsy. [PDF]

Epilepsy Curr
Freedman D, Babatunde I, Morgan RL, Abu-Sawwa R, Albert D, Behbahani M, Chapman K, Fecske E, Gaillard WD, Jones M, Meskis MA, Myers LS, Nye K, Oluigbo C, Pfeifer HH, Shellhaas RA, Thompson L, Weiner HL, Wusthoff CJ, Yozawitz E.   +19 more
europepmc   +1 more source

Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease. [PDF]

Curr Hypertens Rep
O'Keeffe J, Kingshill C, Tompson J, South AM, Baker-Smith CM.   +4 more
europepmc   +1 more source

Self‐limited neonatal epilepsy with 2q24.3 duplications: Case series and literature review

Epileptic Disorders, Volume 28, Issue 3, Page 878-883, June 2026.
Abstract Objective To clarify the phenotypic spectrum associated with duplications involving the 2q24.3 region, which includes a cluster of genes encoding sodium channel subunits (SCN1A, SCN2A, SCN3A, SCN7A, and SCN9A). Methods We reviewed our research database for patients with epilepsy and 2q24.3 duplication and performed thorough phenotyping.
Saba Al Rawahi, Kenneth A. Myers
wiley   +1 more source

Effect of Topiramate on Weight Status in Young Children With Severe Obesity. [PDF]

J Endocr Soc
Salama M, Hassan D, Pittock S, Lteif A, Kumar S.   +4 more
europepmc   +1 more source

Stiripentol: Unpublished results from the first phase 2 clinical trial in Lennox–Gastaut syndrome conducted in the early 1990s

Epilepsia, Volume 67, Issue 6, Page 2845-2854, June 2026.
Abstract Objective This study was undertaken to present the results of an exploratory phase 2 trial of stiripentol in Lennox–Gastaut syndrome (LGS). Methods This exploratory single‐blind, single‐arm, nonrandomized sequential‐period phase 2 study was conducted at four centers in France between January 1989 and August 1993.
Stéphane Auvin, Benjamin Serraz, Jérémie Lespinasse, Laurent Chancharme   +3 more
wiley   +1 more source

Addressing Tamoxifen-Associated Weight Gain: Lifestyle and Pharmacotherapy Options. [PDF]

J Adv Pract Oncol
Fore-Williams L, Distler M.
europepmc   +1 more source

Did the French pregnancy pictogram change antiseizure medication use during pregnancy?

Epilepsia, Volume 67, Issue 6, Page 2864-2874, June 2026.
Abstract Objective The aim of this study was to assess the impact of introducing a pregnancy pictogram on medication packaging on the prescription and dispensation of antiseizure medications and on the maternal and neonatal outcomes for women exposed to these medications.
Mélanie Araujo, Christine Damase‐Michel, Marie Denuelle, Sébastien Boulogne, Laurane Delteil, Monica Saucedo, Catherine Deneux‐Tharaux, Isabelle Lacroix   +7 more
wiley   +1 more source

Botulinum Toxin Type A for the Prevention of Migraines: An Umbrella Review of Systematic Reviews. [PDF]

Toxins (Basel)
Chamani G, Jasim H, Minston A, Dias MF, Poluha RL, Gonçalves DAG, Christidis M, Al-Moraissi EA, Christidis N, De la Torre Canales G, Ernberg M.   +10 more
europepmc   +1 more source

Soticlestat as an adjunctive therapy in children and young adults with Dravet syndrome

Epilepsia, Volume 67, Issue 6, Page 2796-2807, June 2026.
Overview of the phase 3 trial evaluating soticlestat as adjunctive therapy in children and young adults with Dravet syndrome. Abstract Objective This study evaluated the efficacy, safety, and tolerability of soticlestat as adjunctive therapy in children and young adults with Dravet syndrome (DS).
Joseph Sullivan, Kette Valente, Vicente Villanueva, Adam Strzelczyk, Rima Nabbout, Eiji Nakagawa, Yuehua Zhang, Marta Zolnowska, Yasir Khan, Cheng Dong, Samuel Hsiao, Sarah I. Sheikh, Philipp von Rosenstiel, Mahnaz Asgharnejad, Venkatesha Murthy   +14 more
wiley   +1 more source

Long-term effects of carbamazepine on bone-related biochemical markers in patients with epilepsy. [PDF]

Acta Epileptol
Hakami AY, Althagafi AA, Alkhayat AS, Alturkistani BA, Mawar HE, Ibrahim IH, Abualhamail H, Ahmed ME.   +7 more
europepmc   +1 more source